Faculty

Research

Systems

Infrastructure

Patient & Public Awareness

Working with Industry

Research Databases

About Us

News: Diabetes drug could hold key for Parkinson's patients

Title

Diabetes drug could hold key for Parkinson's patients 

News Title

Diabetes drug could hold key for Parkinson's patients 

News Content

A drug used to treat patients with diabetes could offer fresh hope to those affected by the debilitating symptoms of Parkinson’s disease (PD), according to NIHR UCL Hospitals Biomedical Research Centre supported research at the UCL Institute of Neurology and the National Hospital for Neurology and Neurosurgery (NHNN). PD patients on the trial were divided into two groups: 20 patients received Exenatide injections (approved for diabetes care) for 12 months, while the other group of 24 patients served as controls. After one year of treatment patients receiving Exenatide displayed improved cognitive ability and motor skills, while control patients declined.

News Link

Read more 

News Date

24/05/2013 

Expires

24/06/2013 

Date Created

 

Date Modified

 
Attachments
Created at 24/05/2013 14:35  by Leonilde Yahyaoui 
Last modified at 24/05/2013 14:35  by Leonilde Yahyaoui